Evidence map›Paper›PMID 34681641›Full record

ReviewInternational journal of molecular sciences2021

G-Quadruplex Targeting in the Fight against Viruses: An Update.

Emanuela Ruggiero, Irene Zanin, Marianna Terreri, Sara N Richter

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 105 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Comprehensive analysis and validation of mBMC veterinary research · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Emanuela RuggieroDepartment of Molecular Medicine, University of Padua, 35121 Padua, Italy.ORCID 0000-0003-0989-4074
Irene ZaninDepartment of Molecular Medicine, University of Padua, 35121 Padua, Italy.
Marianna TerreriDepartment of Molecular Medicine, University of Padua, 35121 Padua, Italy.
Sara N RichterDepartment of Molecular Medicine, University of Padua, 35121 Padua, Italy.ORCID 0000-0002-5446-9029
University of Padua · IT

Funding

Bill & Melinda Gates Foundation OPP1035881, OPP1097238
6 · The paper itself

Abstract

G-quadruplexes (G4s) are noncanonical nucleic acid structures involved in the regulation of key cellular processes, such as transcription and replication. Since their discovery, G4s have been mainly investigated for their role in cancer and as targets in anticancer therapy. More recently, exploration of the presence and role of G4s in viral genomes has led to the discovery of G4-regulated key viral pathways. In this context, employment of selective G4 ligands has helped to understand the complexity of G4-mediated mechanisms in the viral life cycle, and highlighted the possibility to target viral G4s as an emerging antiviral approach. Research in this field is growing at a fast pace, providing increasing evidence of the antiviral activity of old and new G4 ligands. This review aims to provide a punctual update on the literature on G4 ligands exploited in virology. Different classes of G4 binders are described, with emphasis on possible antiviral applications in emerging diseases, such as the current COVID-19 pandemic. Strengths and weaknesses of G4 targeting in viruses are discussed.

Indexed as

G-QuadruplexesAntiviral AgentsCOVID-19COVID-19 Drug TreatmentDNA, ViralHumansLigandsMicroRNAsRNA, ViralSARS-CoV-2Virus DiseasesAntiviral AgentsDNA, ViralLigandsMicroRNAsRNA, Viralantiviral therapyG-quadruplexesG-quadruplex ligandstargetingvirus

Identifiers

PMID34681641
PMCPMC8538215
OpenAlexW3206397693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.